Table 4.
Patient and disease characteristics by melanoma status in the validation data
| Characteristic | Nonmelanoma (N = 229)1 | Melanoma (N = 11)1 | p value2 |
|---|---|---|---|
| Gender | |||
| Female | 151 (66) | 4 (36) | 0.056 |
| Male | 78 (34) | 7 (64) | |
| Symptoms | 14 (6.1) | 3 (27) | 0.034 |
| Distance from optic disc | |||
| <3 mm | 62 (27) | 5 (45) | 0.2 |
| ≥3 mm | 167 (73) | 6 (55) | |
| Distance from fovea | |||
| <3 mm | 62 (27) | 8 (73) | 0.003 |
| ≥3 mm | 167 (73) | 3 (27) | |
| Largest basal diameter, mm | 6.00 (4.00, 8.00) | 6.00 (5.25, 7.00) | 0.3 |
| Height, mm | 1.28 (1.00, 1.50) | 2.00 (1.94, 3.00) | <0.001 |
| SRF | 11 (4.8) | 0 (0) | >0.9 |
| Orange pigment | 6 (2.6) | 3 (27) | 0.005 |
| Drusen | 176 (77) | 7 (64) | 0.3 |
| RPE atrophy | 140 (62) | 8 (73) | 0.8 |
| Unknown | 5 | 0 |
SRF, subretinal fluid; RPE, retinal pigment epithelium.
1
Statistics presented: n (%); median (IQR).
2
Statistical tests performed: Fisher's exact test; Wilcoxon rank-sum test.